GENFF (Genflow Biosciences) Total Liabilities: $1.34 Mil (As of Dec. 2025)


What is Genflow Biosciences Total Liabilities?

Genflow Biosciences GENFF Total Liabilities is $1.34 Mil as of Dec. 2025. The stock has 1 warning sign investors should review.

Genflow Biosciences's Total Liabilities for the quarter that ended in Dec. 2025 was $1.34 Mil.

Genflow Biosciences's quarterly Total Liabilities increased from Dec. 2024 ($1.00 Mil) to Jun. 2025 ($1.05 Mil) and increased from Jun. 2025 ($1.05 Mil) to Dec. 2025 ($1.34 Mil).

Genflow Biosciences's annual Total Liabilities increased from Dec. 2023 ($0.72 Mil) to Dec. 2024 ($1.00 Mil) and increased from Dec. 2024 ($1.00 Mil) to Dec. 2025 ($1.34 Mil).

Genflow Biosciences Total Liabilities Historical Data

* Premium members only.

The historical data trend for Genflow Biosciences's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Genflow Biosciences Total Liabilities Chart

Genflow Biosciences Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
Total Liabilities
0.29 0.31 0.72 1.00 1.34

Genflow Biosciences Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.72 0.63 1.00 1.05 1.34

Genflow Biosciences Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

Genflow Biosciences's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.343+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.34

Total Liabilities=Total Assets (A: Dec. 2025 )-Total Equity (A: Dec. 2025 )
=0.605--0.738
=1.34

Genflow Biosciences's Total Liabilities for the quarter that ended in Dec. 2025 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1.343+(0+0
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit+NonCurrent Deferred Income Tax)
+0+0+0)
=1.34

Total Liabilities=Total Assets (Q: Dec. 2025 )-Total Equity (Q: Dec. 2025 )
=0.605--0.738
=1.34

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Total Liabilities →
What does a Total Liabilities of $1.34 Mil mean?
Genflow Biosciences (GENFF) has a Total Liabilities of $1.34 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genflow Biosciences and its competitors.
Is Genflow Biosciences' Total Liabilities too high?
Genflow Biosciences' current Total Liabilities is $1.34 Mil.
How does Genflow Biosciences' Total Liabilities compare to VRTX and REGN?
Genflow Biosciences' Total Liabilities of $1.34 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Biotechnology company?
A good Total Liabilities depends on the Biotechnology industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Genflow Biosciences and its competitors. Genflow Biosciences's current Total Liabilities is $1.34 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Genflow Biosciences stock overvalued right now?
Genflow Biosciences (GENFF) has a current Total Liabilities of $1.34 Mil. The current Total Liabilities is $1.34 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Genflow Biosciences (GENFF), the current Total Liabilities is $1.34 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Genflow Biosciences Business Description

Other Exchanges GENF:UKWQ5:Germany
Address 6 Heddon Street, London, GBR, W1B 4BT
Genflow Biosciences PLC is a preclinical biotechnology company focused on the development of biological interventions (namely gene therapies) which are aimed at tackling the effects of aging, potentially slowing or halting the aging process and so reducing the incidence of age-related diseases and thereby increasing health span. Its flagship compound, GF-1002, is based on the delivery of a variant of the SIRT6 gene and is currently in preclinical development.